InsiderTrades

Form 4 for IART INTEGRA LIFESCIENCES HOLDINGS CORP

Accepted 2024-01-19 00:00:00 ET · period of report 2024-01-18 · accession 0000917520-24-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-01-19 2024-01-18 IART De Witte Jan Pres, CEO, Dir F - Tax $42.39 -597 18.4K -3% -$25.3K
D 2024-01-19 2024-01-18 IART De Witte Jan Pres, CEO, Dir M - OptEx $0.00 +597 18.9K +3% $0
D 2024-01-19 2024-01-18 IART De Witte Jan Pres, CEO, Dir M - OptEx $0.00 -597 89.4K -0.7% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-18 F D 597 $42.39 18,350 D — —
2 Common Common Stock 2024-01-18 M A 597 $0.00 18,947 D — —
3 Derivative Restricted Stock Units 2024-01-18 M D 597 $0.00 89,417 D $0.00 · — to — 597 Common Stock (F1) The award was a restricted stock unit award which vests in three annual equal installments on the first, second and third anniversaries of the grant date of 1/18/2022 of which the second installment vested on 1/18/2024 and which shall be delivered to Mr. De Witte within 30 days following the first business day that occurs immediately following the six-month period after the date of his separation of service as deferred compensation.